Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hem-1 regulates protective humoral immunity and limits autoantibody production in a B cell–specific manner
Alan Avalos, Jacob T. Tietsort, Nutthakarn Suwankitwat, Jonathan D. Woods, Shaun W. Jackson, Alexandra Christodoulou, Christopher Morrill, H. Denny Liggitt, Chengsong Zhu, Quan-Zhen Li, Kevin K. Bui, Heon Park, Brian M. Iritani
Alan Avalos, Jacob T. Tietsort, Nutthakarn Suwankitwat, Jonathan D. Woods, Shaun W. Jackson, Alexandra Christodoulou, Christopher Morrill, H. Denny Liggitt, Chengsong Zhu, Quan-Zhen Li, Kevin K. Bui, Heon Park, Brian M. Iritani
View: Text | PDF
Research Article Immunology

Hem-1 regulates protective humoral immunity and limits autoantibody production in a B cell–specific manner

  • Text
  • PDF
Abstract

Hematopoietic protein-1 (Hem-1) is a member of the actin-regulatory WASp family verprolin homolog (WAVE) complex. Loss-of-function variants in the NCKAP1L gene encoding Hem-1 were recently discovered to result in primary immunodeficiency disease (PID) in children, characterized by poor specific Ab responses, increased autoantibodies, and high mortality. However, the mechanisms of how Hem-1 deficiency results in PID are unclear. In this study, we utilized constitutive and B cell–specific Nckap1l-KO mice to dissect the importance of Hem-1 in B cell development and functions. B cell–specific disruption of Hem-1 resulted in reduced numbers of recirculating follicular (FO), marginal zone (MZ), and B1 B cells. B cell migration in response to CXCL12 and -13 were reduced. T-independent Ab responses were nearly abolished, resulting in failed protective immunity to Streptococcus pneumoniae challenge. In contrast, T-dependent IgM and IgG2c, memory B cell, and plasma cell responses were more robust relative to WT control mice. B cell–specific Hem-1–deficient mice had increased autoantibodies against multiple autoantigens, and this correlated with hyperresponsive BCR signaling and increased representation of CD11c+T-bet+ age-associated B cell (ABC cells) — alterations associated with autoimmune diseases. These results suggest that dysfunctional B cells may be part of a mechanism explaining why loss-of-function Hem-1 variants result in recurring infections and autoimmunity.

Authors

Alan Avalos, Jacob T. Tietsort, Nutthakarn Suwankitwat, Jonathan D. Woods, Shaun W. Jackson, Alexandra Christodoulou, Christopher Morrill, H. Denny Liggitt, Chengsong Zhu, Quan-Zhen Li, Kevin K. Bui, Heon Park, Brian M. Iritani

×

Figure 5

Hem-1 is required for optimal TI Ab production and protection against Streptococcus pneumoniae challenge.

Options: View larger image (or click on image) Download as PowerPoint
Hem-1 is required for optimal TI Ab production and protection against St...
(A and B) WT and Hem1fl/flMb1Cre mice (n = 4 and n = 5) were immunized with 50 μg/mL NP-Ficoll. (A) ELISA plates were coated with NP-BSA30 (10 μg/mL), and Ab production was measured 6 days after immunization. Shown is a graph depicting absorbance at 405 nm versus serum dilution. (B) BM was harvested from immunized mice 6 days after immunization. Cells were stained for fluorescent conjugated antibodies against the indicated markers for flow cytometric analyses. Shown are representative dot plot histograms and bar graphs quantifying the percentages of total plasma cells (B220–CD138+) (top) and NP-specific plasma cells (bottom). Each data point is representative of an individual mouse, and data were derived from a single experiment. (C) ELISA plates were coated with 50 μg/mL PC-BSA and used to determined IgM production 5 days after i.v. immunization with 1 × 107 cfu heat-killed Streptococcus pneumoniae (HKSP). Shown are graphs depicting the absorbance at 405 nm versus serum dilution. (D and E) WT, Hem1–/–, and Hem1fl/flMb1Cre mice (n = 14, 5, and 5) were immunized with HKSP. Immunized (imm) mice, and unimmunized WT control mice (n = 4), were challenged with 1 × 107 cfu live Spn and were monitored daily. (D) A graph depicting BW loss versus days after infection. (E) A Kaplan-Meier survival curve for each group. Data points represent individual mice, and data were combined from 2 independent experiments. Data represent mean ± SEM and were analyzed via unpaired Student’s t test (A–C) or the Gehan-Breslow-Wilcoxon test using GraphPad prism (E). Shown are individual comparisons. For multiple comparisons using ANOVA, P < 0.0001. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts